Search

Your search keyword '"Wojciechowska C"' showing total 85 results

Search Constraints

Start Over You searched for: Author "Wojciechowska C" Remove constraint Author: "Wojciechowska C" Language english Remove constraint Language: english
85 results on '"Wojciechowska C"'

Search Results

13. Ezetimibe added to statin therapy after acute coronary syndromes

19. Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome

23. Evaluation of usefulness of combine nitroprusside, nitric oxide, sildenafil vasodilatative test in reversibility of pulmonary venous hypertension in dilated cardiomyopathy patients

24. Echocardiografic evaluation, physical capacity and NTproBNP concentration in dilated cardiomyopathy patients wit low and elevated trasnspulmonary gradient

26. The Role of Oxidative Stress and Inflammatory Parameters in Heart Failure.

27. Association of NT-proBNP and sST2 with Left Ventricular Ejection Fraction and Oxidative Stress in Patients with Stable Dilated Cardiomyopathy.

28. The Impact of Pharmacotherapy for Heart Failure on Oxidative Stress-Role of New Drugs, Flozins.

29. Pregnancy in Patients with Pulmonary Arterial Hypertension in Light of New ESC Guidelines on Pulmonary Hypertension.

30. Pathomechanisms of SARS-CoV-2 infection and development of atherosclerosis in patients with COVID-19: A review.

31. Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI?

32. Ceruloplasmin as Redox Marker Related to Heart Failure Severity.

33. Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy.

34. DIAGNOSTIC AND PREDICTIVE VALUE OF RIGHT HEART CATHETERIZATION-DERIVED MEASUREMENTS IN PULMONARY HYPERTENSION.

35. Decreased immunoreactivity of von Willebrand factor may reflect persistent nature of the endothelial dysfunction in non-ischemic heart failure.

36. Nitric Oxide Stroke Volume Index as a New Hemodynamic Prognostic Parameter for Patients with Pulmonary Arterial Hypertension.

37. Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients.

38. Malondialdehyde and Uric Acid as Predictors of Adverse Outcome in Patients with Chronic Heart Failure.

39. Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology.

41. The concentration of interleukin-33 in heart failure with reduced ejection fraction.

42. Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy.

43. The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax.

44. Author`s Reply.

45. Prognostic Factors in Patients with an Implanted Pacemaker after 80 Years of Age in a 4-Year Follow-Up.

46. Complications of electrotherapy - the dark side of treatment with cardiac implantable electronic devices.

47. Ten-year study of late electrotherapy complications. Single-centre analysis of indications and safety of transvenous leads extraction.

48. Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients.

49. The effect of BMI, serum leptin, and adiponectin levels on prognosis in patients with non-ischaemic dilated cardiomyopathy.

50. Impact of septal flash and left ventricle contractile reserve on positive remodeling during 1 year cardiac resynchronization therapy: the multicenter ViaCRT study.

Catalog

Books, media, physical & digital resources